Our generics consulting team is prepared to help your company face some of today’s most pressing challenges.
Speed to Market
The ability to quickly bring a generic drug to market is paramount in the generics industry. Requiring a complex orchestration of multiple internal and external stakeholders, this brings with it a cascading array of potential challenges.
Pricing Challenges Remain
Steadily increasing competition and fluctuating demand has created a significant pricing challenge for the industry. Regulations across the U.S. and globe have already been enacted or drafted in an effort to manage drug pricing through government intervention.
Supply Chain Issues
Access to raw ingredients and API has waned considerably following the onset of the global COVID-19 pandemic, creating significant supply pressures on generic drug makers. Furthermore, changes to patient behavior have also led to fluctuations in demand.
The Mandate for Digital
As patients and providers move more and more interactions to the digital landscape, generics makers must adopt new strategies for sales, patient and provider engagement, education, and more.
Though regulations are in place to address the issue, counterfeiting remains a substantial threat to generic drugmakers in terms of patient safety, brand protection, and revenue.
Generic Pharmaceutical Manufacturer
Patient Centricity Assessment and Strategy
Increased awareness, commitment to, and common language around patient centricity across the specialty marketing organization team and leadership
Activities outlined will grow patient centricity at the organization from Level 2 to Level 4 on the Patient Centricity Maturity Model
Brand planning materials now include >500% additional mentions, interactions, and approaches to include patient-centric thinking into key planning elements